For Quick Alerts
For Daily Alerts

Divi's Lab Nosedives Nearly 20% On US FDA Alert

By Religare

Shares of Divi's Laboratories plunged nearly 20 per cent on the Bombay Stock Exchange after the company said that US-FDA has issued an Import Alert 66-40 on the products manufactured at the company's Unit-II at Visakhapatnam, Andhra Pradesh.

Divi's Lab Nosedives Nearly 20% On US FDA Alert
Weighed down by the development, shares of company declined as much as 19.69 per cent to hit intra-day low of Rs 635.00 apiece on the Bombay Stock Exchange.

In a similar fashion, stocks of company slipped 18.49 per cent to Rs 640.90 apiece on the National Stock Exchange.

Meanwhile, the broader benchmark BSE Sensex was trading at 29,428.42, down 90.32 points or 0.31 per cent, at 11:55 hours.

    Read more about: divis laboratories
    Company Search
    Get Instant News Updates
    Notification Settings X
    Time Settings
    Clear Notification X
    Do you want to clear all the notifications from your inbox?
    Settings X
    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more